health
Biden's favor to Trump on cheaper drug prices includes a largely forgotten law to make Medicare more powerful
President Donald Trump has been taking credit for new federal data that shows U.S. prescription drug prices fell 0.8% in July and are down 3.1% from a year ago, the steepest year-over-year drop since 1963.
TL;DR
- U.S. prescription drug prices have fallen, with the steepest year-over-year drop since 1963.
- President Trump claims credit for the price reduction due to his 'most favored nation' drug deals and the TrumpRx website.
- Drug pricing experts attribute the decline to multiple factors, including market competition from generic and biosimilar drugs.
- Legislation from the Biden administration, specifically the Inflation Reduction Act allowing Medicare to negotiate drug prices, is also seen as a significant contributor.
- The prescription drug price index measures pharmacy revenue, not direct consumer costs, so consumers may not fully see the savings.
- The actual impact of Trump's 'most favored nation' deals is unclear as contracts are not public and models are still in development.
- While TrumpRx offers price transparency, its usage and the reliability of claimed savings are questioned.